# Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors

> **NCT04268368** · — · UNKNOWN · sponsor: **Università Politecnica delle Marche** · enrollment: 200 (estimated)

## Conditions studied

- Cancer
- Lung Cancer
- Renal Cell Carcinoma
- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04268368
- **Lead sponsor:** Università Politecnica delle Marche
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04268368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04268368, "Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04268368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*